Italia markets closed

BMY May 2025 50.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,6100+0,4500 (+20,83%)
Alla chiusura: 01:12PM EDT
Schermo intero
Chiusura precedente2,1600
Aperto2,6000
Denaro2,2900
Lettera2,7700
Prezzo d'esercizio50,00
Scadenza2025-05-16
Min-Max giorno2,5000 - 2,6100
Contratto - Min-MaxN/D
Volume21
Open Interest941
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri